Green Tea in Reproductive Cancers: Could Treatment Be as Simple?

Maclaine Parish, Gaelle Massoud, Dana Hazimeh, James Segars, Md Soriful Islam

Research output: Contribution to journalReview articlepeer-review


Green tea originates from the tea plant Camellia sinensis and is one of the most widely consumed beverages worldwide. Green tea polyphenols, commonly known as catechins, are the major bioactive ingredients and account for green tea’s unique health benefits. Epigallocatechin-3-gallate (EGCG), is the most potent catechin derivative and has been widely studied for its pro- and anti-oxidative effects. This review summarizes the chemical and chemopreventive properties of green tea in the context of female reproductive cancers. A comprehensive search of PubMed and Google Scholar up to December 2022 was conducted. All original and review articles related to green tea or EGCG, and gynecological cancers published in English were included. The findings of several in vitro, in vivo, and epidemiological studies examining the effect of green tea on reproductive cancers, including ovarian, cervical, endometrial, and vulvar cancers, are presented. Studies have shown that this compound targets specific receptors and intracellular signaling pathways involved in cancer pathogenesis. The potential benefits of using green tea in the treatment of reproductive cancers, alone or in conjunction with chemotherapeutic agents, are examined, shedding light on new therapeutic strategies for the management of female reproductive cancers.

Original languageEnglish (US)
Article number862
Issue number3
StatePublished - Feb 2023


  • EGCG
  • antioxidant
  • cervical cancer
  • endometrial cancer
  • green tea
  • ovarian cancer
  • pro-oxidant
  • reproductive cancers

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Green Tea in Reproductive Cancers: Could Treatment Be as Simple?'. Together they form a unique fingerprint.

Cite this